Johnson And Johnson's ability to collect accounts receivable sequentially worsen to 5.47, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Average collection period, for Johnson And Johnson's accounts receivable remained unchanged at 67 days, in the Jun 28 2026 quarter.

If we take a look into Healthcare sector 334 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 28 2026 from 2396 to 2397.

What is Receivable Turnover Ratio?
What is Johnson And Johnson Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

JNJ Receivables Turnover Ratio	(Jun 28 2026) II. Quarter	(Mar 29 2026) I. Quarter	(Dec 28 2025) IV. Quarter	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter
Y / Y Receivable Change	6.72 %	10.62 %	15.74 %	8.88 %	12.99 %
Y / Y Revenue Change	6.6 %	9.91 %	9.08 %	6.77 %	5.77 %
Receivable Turnover Ratio (TTM)	5.47	5.48	5.49	5.56	5.59
JNJ's Total Ranking	# 2397	# 2396	# 2233	# 2277	# 2149
Accounts Receivable average collection period days	67	67	67	66	65
Seq. Receivable Change	7.48 %	3.16 %	-2.46 %	-1.32 %	11.4 %
Seq. Revenue Change	5.19 %	-2.04 %	2.38 %	1.05 %	8.45 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 96
Healthcare Sector	# 335
Overall Market	# 2397

Receivable Turnover Ratio Statistics
High	Average	Low
7.06	6.08	5.47
(Sep. 30, 2005)		(Jun 28 2026)

JNJ Company Profile • Back to JNJ Efficiency Comparisons • Compare JNJ Receivables Turnover Ratio to its Competitors

Financial Statements
Johnson And Johnson's Accounts Receivable	$ 19,046 Millions	Visit JNJ's Balance sheet
Johnson And Johnson's Sales TTM	$ 97,929 Millions	Visit JNJ's Income Statement
Sources of JNJ's Revenues		Visit JNJ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
JNJ's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
JNJ's Growth Rates	JNJ's Roa	JNJ's Inventory Turnover Ratio	JNJ's Dividend Comparisons
JNJ's Profitability Ratios	JNJ's Roi	JNJ's Asset Turnover Ratio	JNJ's Dividend Growth
JNJ's Valuation Ratios	JNJ's Roe	JNJ's Financial Strength Ratios	JNJ's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 28 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 28 2026	Receivable at quarter ending Jun 28 2026
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Talkspace Inc	14.09	$ 246.631 Millions	$ 17.506 Millions
Lifestance Health Group Inc	14.07	$ 1,584.834 Millions	$ 112.665 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Amneal Pharmaceuticals Inc	13.83	$ 3,117.474 Millions	$ 225.492 Millions
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Corcept Therapeutics Inc	13.30	$ 830.813 Millions	$ 62.477 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Skinhealth Systems Inc	13.04	$ 289.224 Millions	$ 22.179 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Mannkind Corporation	12.39	$ 393.630 Millions	$ 31.773 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.82	$ 8.855 Millions	$ 0.749 Millions
Marpai Inc	11.71	$ 16.635 Millions	$ 1.420 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Kymera Therapeutics Inc	10.50	$ 105.000 Millions	$ 10.000 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions

Date modified: 2026-09-05T07:03:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.